CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2012-03-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00262-012-1245-1PMID 22441657PMCID PMC11028868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion

  2012cited by this paper
• Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients

  2010cited by this paper
• Expression profiles of proliferative and antiapoptotic genes in sporadic and colitis‐related mouse colon cancer models

  2010cited by this paper
• Systemic dysregulation of CEACAM1 in melanoma patients

  2010cited by this paper
• Enrichment of Foxp3+ CD4 Regulatory T Cells in Migrated T Cells to IL-6– and IL-8–Expressing Tumors through Predominant Induction of CXCR1 by IL-6

  2010cited by this paper
• Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses

  2010cited by this paper
• Selected Murine Residues Endow Human TCR with Enhanced Tumor Recognition

  2010cited by this paper
• Minimally Cultured or Selected Autologous Tumor-infiltrating Lymphocytes After a Lympho-depleting Chemotherapy Regimen in Metastatic Melanoma Patients

  2009cited by this paper
• Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones.

  2009cited by this paper
• Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack

  2009cited by this paper
• Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment.

  2009influential reference
• Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.

  2009cited by this paper
• Adoptive cell therapy for the treatment of patients with metastatic melanoma.

  2009cited by this paper
• Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.

  2008cited by this paper
• Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression.

  2008cited by this paper
• Adoptive cell transfer: a clinical path to effective cancer immunotherapy

  2008cited by this paper
• Chemokines: coded messages for T-cell missions.

  2008cited by this paper
• Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

  2008cited by this paper
• Chemotaxis, chemokine receptors and human disease.

  2008cited by this paper
• Failure at the Effector Phase: Immune Barriers at the Level of the Melanoma Tumor Microenvironment

  2007cited by this paper
• Tissue prognostic markers for adoptive immunotherapy in melanoma.

  2007cited by this paper
• Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

  2006cited by this paper
• Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.

  2006cited by this paper
• Migration of cytotoxic T lymphocytes toward melanoma cells in three‐dimensional organotypic culture is dependent on CCL2 and CCR4

  2006influential reference
• Polymorphisms in interleukin 8 and its receptors (IL8, IL8RA and IL8RB) and association of common IL8 receptor variants with peripheral blood eosinophil counts

  2006cited by this paper
• Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.

  2006cited by this paper
• Immune resistance orchestrated by the tumor microenvironment

  2006cited by this paper
• Cyclooxygenase Regulates Cell Surface Expression of CXCR3/1-Storing Granules in Human CD4+ T Cells1

  2006cited by this paper
• Inhibition of Human Tumor-Infiltrating Lymphocyte Effector Functions by the Homophilic Carcinoembryonic Cell Adhesion Molecule 1 Interactions1

  2006cited by this paper
• Murine B16 Melanomas Expressing High Levels of the Chemokine Stromal-Derived Factor-1/CXCL12 Induce Tumor-Specific T Cell Chemorepulsion and Escape from Immune Control1

  2006cited by this paper
• High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation.

  2006cited by this paper
• Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.

  2005cited by this paper
• Persistence of Multiple Tumor-Specific T-Cell Clones Is Associated with Complete Tumor Regression in a Melanoma Patient Receiving Adoptive Cell Transfer Therapy

  2005cited by this paper
• Human CD8+ T cells store CXCR1 in a distinct intracellular compartment and up-regulate it rapidly to the cell surface upon activation.

  2005cited by this paper
• Tumor Progression Can Occur despite the Induction of Very High Levels of Self/Tumor Antigen-Specific CD8+ T Cells in Patients with Melanoma

  2005cited by this paper
• CXC Chemokine Ligand 12 (Stromal Cell-Derived Factor 1α) and CXCR4-Dependent Migration of CTLs toward Melanoma Cells in Organotypic Culture1

  2005cited by this paper
• Cancer and the chemokine network

  2004cited by this paper
• IL-8 responsiveness defines a subset of CD8 T cells poised to kill.

  2004influential reference
• CXCR2- and E-Selectin–induced Neutrophil Arrest during Inflammation In Vivo

  2004cited by this paper
• Ligand Selectivity and Affinity of Chemokine Receptor CXCR1

  2004cited by this paper
• Survival and Tumor Localization of Adoptively Transferred Melan-A-Specific T Cells in Melanoma Patients 1

  2003cited by this paper
• Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma.

  2003cited by this paper
• Chemokines in cancer.

  2002cited by this paper
• Clinical-Scale Selection of Anti-CD3/CD28–Activated T Cells After Transduction with a Retroviral Vector Expressing Herpes Simplex Virus Thymidine Kinase and Truncated Nerve Growth Factor Receptor

  2002cited by this paper
• Redirecting Migration of T Cells to Chemokine Secreted from Tumors by Genetic Modification with CXCR2

  2002cited by this paper
• Expression and regulation of chemokine receptors in human natural killer cells.

  2001cited by this paper
• Naturally Occurring Deletional Mutation in the C-Terminal Cytoplasmic Tail of CCR5 Affects Surface Trafficking of CCR5

  2001cited by this paper
• Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.

  2000cited by this paper
• Strong expression of the lymphoattractant C‐X‐C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma

  1999cited by this paper
• Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A.

  1997cited by this paper
• The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2.

  1997cited by this paper
• Mast cells as potent inflammatory cells.

  1996cited by this paper
• Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes.

  1994cited by this paper
• Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma.

  1989cited by this paper
• Melanoma growth stimulatory activity: Isolation from human melanoma tumors and characterization of tissue distribution

  1988cited by this paper
• Transfer Therapy Cancer Regression in Patients Receiving Cell Lymphocyte Clonotypes Correlates with Cutting Edge: Persistence of Transferred

  year unknowncited by this paper

• Redirecting engineered immune cells using G protein-coupled receptors in cancer therapy

  2026cites this paper
• The Critical Role of Homing in TIL Therapy Success: From Biology to Clinical Application.

  2025cites this paper
• The Clinical Significance and Involvement in Molecular Cancer Processes of Chemokine CXCL1 in Selected Tumors

  2024cites this paper
• Construction of self-driving anti-αFR CAR-engineered NK cells based on IFN-γ and TNF-α synergistically induced high expression of CXCL10

  2024cites this paper
• Chimeric antigen receptor-T cells targeting epithelial cell adhesion molecule antigens are effective in the treatment of colorectal cancer

  2024cites this paper
• Advances in adoptive T-cell therapy for metastatic melanoma.

  2023cites this paper
• Relation Between Baseline CXCR1 Expression And Neoadjuvant Chemotherapy Response In Breast Cancer Patients.

  2023cites this paper
• Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis

  2023cites this paper
• CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer

  2022cites this paper
• Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges

  2022cites this paper
• Adenosine-deaminase-acting-on-RNA-1 facilitates T-cell migration toward human melanoma cells.

  2022cites this paper
• Reversing chemokine/chemokine receptor mismatch to enhance the antitumor efficacy of CAR-T cells.

  2022cites this paper
• Adoptive T-cell Immunotherapy: Perfecting Self-Defenses.

  2022cites this paper
• Associations of immune cell homing gene signatures and infiltrates of lymphocyte subsets in human melanomas: discordance with CD163+ myeloid cell infiltrates

  2021influential citation
• Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?

  2021cites this paper
• Progress in research of tumor infiltrating lymphocytes in pancreatic cancer

  2021cites this paper
• Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential

  2021cites this paper
• Adoptive T-Cell Therapy: Optimizing Chemokine Receptor-Mediated Homing of T-Cells in Cancer Immunotherapy

  2020cites this paper
• 11β hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma

  2020cites this paper
• The Complexity of Targeting Chemokines to Promote a Tumor Immune Response

  2020cites this paper
• Tumor-infiltrating lymphocytes: Warriors fight against tumors powerfully.

  2020cites this paper
• Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer.

  2020cites this paper
• Targeting glycosylated antigens on cancer cells using siglec‐7/9‐based CAR T‐cells

  2020cites this paper
• CAR T cells for brain tumors: Lessons learned and road ahead

  2019cites this paper
• T-cells "à la CAR-T(e)" - Genetically engineering T-cell response against cancer.

  2019cites this paper
• Enhancing tumor T cell infiltration to enable cancer immunotherapy.

  2019cites this paper
• Chimeric antigen receptor T cells in solid tumors: a war against the tumor microenvironment

  2019cites this paper
• CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts

  2019cites this paper
• Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site

  2018cites this paper
• Immune Cell Migration in Cancer and Immunotherapy

  2018cites this paper
• Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model

  2018cites this paper
• Reincke Gene expression profiles of T cells after adoptive transfer in a mouse model of pancreatic carcinoma

  2017cites this paper
• Expression characteristic of CXCR1 in different breast tissues and the relevance between its expression and efficacy of neo-adjuvant chemotherapy in breast cancer

  2017cites this paper
• Improving homing in T cell therapy.

  2017cites this paper
• T-Lymphocyte Homing: An Underappreciated yet Critical Hurdle for Successful Cancer Immunotherapy

  2017cites this paper
• Adoptive T cell therapy: An overview of obstacles and opportunities

  2017cites this paper
• Adoptive cell therapy: past, present and future.

  2017cites this paper
• Chapter 2 The Metastatic Microenvironment

  2017cites this paper
• Genetics of primary sclerosing cholangitis and pathophysiological implications

  2017cites this paper
• Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients

  2016cites this paper
• Lymphocytes t transduits exprimant cxcr6 pour la thérapie tumorale ciblée

  2016cites this paper
• Novel Treatments in Development for Melanoma.

  2016cites this paper
• Adoptive T-Cell Therapy: Optimizing Chemokine Receptor-Mediated Homing of T-Cells in Cancer Immunotherapy

  2015cites this paper
• Tumor-Infiltrating Lymphocyte Therapy: Addressing Prevailing Questions

  2015cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2014cites this paper
• A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy

  2014cites this paper
• The Metastatic Microenvironment

  2013cites this paper
• Adoptive T-cell transfer in melanoma.

  2013cites this paper
• Adoptive Immunotherapy of Advanced Melanoma

  2012cites this paper
• Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response.

  2012cites this paper
• CCR1 (chemokine (C-C motif) receptor 1)

  2011cites this paper